Canaccord Genuity Group Reaffirms Buy Rating for TELA Bio (NASDAQ:TELA)

Canaccord Genuity Group restated their buy rating on shares of TELA Bio (NASDAQ:TELA – Get Rating) in a report released on Tuesday, Benzinga reports. Canaccord Genuity Group currently has a $15.00 target price on the stock. Separately, JMP Securities reaffirmed a market outperform rating and set a $20.00 price objective on shares of TELA Bio […]

Related Keywords

,Canaccord Genuity Group ,Susquehanna International Group ,Millennium Management ,Nasdaq ,Morgan Stanley ,Capital Management ,Schonfeld Strategic Advisors ,Bio Inc ,Get Rating ,Genuity Group ,Strategic Advisors ,Ovitex Reinforced Tissue Matrix ,Tissue Matrix ,Robotic Procedures ,Tela Bio ,Nasdaq Tela ,Tutela ,Medical ,Reiterated Rating ,Canaccord Genuity Group Inc ,